Neurocognitive profiles of bipolar disorder patients receiving olanzapine or quetiapine in addition to mood-stabilizers

2024-11-0920210924-977X10.1016/j.euroneuro.2021.10.345http://dx.doi.org/10.1016/j.euroneuro.2021.10.345https://hdl.handle.net/20.500.14288/13309N/AClinical neurologyNeurosciencesPharmacologyPharmacyPsychiatryNeurocognitive profiles of bipolar disorder patients receiving olanzapine or quetiapine in addition to mood-stabilizersMeeting Abstract1873-78627533595003356123